Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 2;25(1):295.
doi: 10.1186/s12931-024-02920-0.

G12/13 signaling in asthma

Affiliations
Review

G12/13 signaling in asthma

Elizabeth L McDuffie et al. Respir Res. .

Erratum in

  • Correction to: G12/13 signaling in asthma.
    McDuffie EL, Panettieri RA Jr, Scott CP. McDuffie EL, et al. Respir Res. 2024 Oct 14;25(1):371. doi: 10.1186/s12931-024-02985-x. Respir Res. 2024. PMID: 39402568 Free PMC article. No abstract available.

Abstract

Shortening of airway smooth muscle and bronchoconstriction are pathognomonic for asthma. Airway shortening occurs through calcium-dependent activation of myosin light chain kinase, and RhoA-dependent calcium sensitization, which inhibits myosin light chain phosphatase. The mechanism through which pro-contractile stimuli activate calcium sensitization is poorly understood. Our review of the literature suggests that pro-contractile G protein coupled receptors likely signal through G12/13 to activate RhoA and mediate calcium sensitization. This hypothesis is consistent with the effects of pro-contractile agonists on RhoA and Rho kinase activation, actin polymerization and myosin light chain phosphorylation. Recognizing the likely role of G12/13 signaling in the pathophysiology of asthma rationalizes the effects of pro-contractile stimuli on airway hyperresponsiveness, immune activation and airway remodeling, and suggests new approaches for asthma treatment.

Keywords: Airway hyperresponsiveness; Airway remodeling; Anticholinergic agents; Asthma; Bronchoconstriction; Calcium sensitization; G12/13; Inflammation; Muscarinic 3 acetylcholine receptor; RhoA.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
G protein signaling in smooth muscle contraction. Two G protein signaling pathways contribute to airway smooth muscle contraction. Activation of Gq/11 upon receptor-dependent guanine nucleotide exchange stimulates the calcium-dependent contractile pathway, whereby GTP-bound Gq/11 allosterically activates PLCβ-dependent hydrolysis of phosphoinositide bisphosphate (PIP2) into IP3 and DAG, which promote intracellular calcium flux, thereby activating MLCK-dependent phosphorylation of myosin light chain and actomyosin cross-bridge cycling (blue nodes on right side of figure). Calcium sensitization (fuchsia and violet nodes in the center and left of the figure) is mediated by GTP-bound RhoA, which can be generated downstream of activation of either Gq/11 or G12/13, although G12/13 are more potent activators [29]. PKC phosphorylation of CPI-17 promotes inhibition of myosin light chain phosphatase, which increases net MLC phosphorylation. GTP-bound RhoA stimulates actin polymerization through activation of formins (fuchsia nodes) and ROCK activity (violet nodes), which inhibit both filament severing and MLCP. ROCK also phosphorylates CPI-17, which further inhibits MLCP. (Created with BioRender.com)
Fig. 2
Fig. 2
G12/13 signaling in inflammation. G12/13-dependent activation of RhoA and ROCK promotes inflammation in both Th2-high (a) and Th2-low asthma (c). G12/13 can also stimulate NFκB-dependent production of inflammatory cytokines (b). (Created with BioRender.com)
Fig. 3
Fig. 3
G12/13 signaling in proliferation. G12/13 activate RhoGEFs that generate GTP-bound RhoA, activating ROCK and stimulating proliferative gene transcription via AP-1 (a) and SRE (b) promoters. GTP-bound RhoA inhibits phosphorylation of Lats 1/2, thereby blocking negative regulation of the Hippo pathway (c). G12/13 bind to c-Abl, affecting ERK-dependent proliferation (d). (Created with BioRender.com)
Fig. 4
Fig. 4
Targets for regulating G12/13 signaling. Hyperactive G12/13 signaling in airway smooth muscle can be attenuated by antagonizing upstream receptors (red), by developing direct inhibitors of G12, G13 (green) or complexes between G12/13 and RhoGEFs (blue), or by inhibiting RhoA or ROCK (purple). (Created with BioRender.com)

References

    1. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol. 2003;63(6):1256–72. - PubMed
    1. Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol. 2002;3(9):639–50. - PubMed
    1. Yang D, Zhou Q, Labroska V, Qin S, Darbalaei S, Wu Y, et al. G protein-coupled receptors: structure- and function-based drug discovery. Signal Transduct Target Ther. 2021;6(1):7. - PMC - PubMed
    1. Hurowitz EH, Melnyk JM, Chen YJ, Kouros-Mehr H, Simon MI, Shizuya H. Genomic characterization of the human heterotrimeric G protein alpha, beta, and gamma subunit genes. DNA Res. 2000;7(2):111–20. - PubMed
    1. Hauser AS, Avet C, Normand C, Mancini A, Inoue A, Bouvier M et al. Common coupling map advances GPCR-G protein selectivity. Elife. 2022;11. - PMC - PubMed

MeSH terms

Substances